• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于适配体的RNA-蛋白降解靶向嵌合体。

The aptamer-based RNA-PROTAC.

作者信息

Xu Yan, Yuan Yi, Fu Ding-Qiang, Fu Yi, Zhou Shan, Yang Wan-Ting, Wang Xu-Yang, Li Guang-Xun, Dong Juan, Du Feng, Huang Xin, Wang Qi-Wei, Tang Zhuo

机构信息

Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu, Sichuan 610041, PR China; Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan 610041, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China.

Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan 610041, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China.

出版信息

Bioorg Med Chem. 2023 May 15;86:117299. doi: 10.1016/j.bmc.2023.117299. Epub 2023 Apr 27.

DOI:10.1016/j.bmc.2023.117299
PMID:37137271
Abstract

RNA-binding proteins (RBPs) dysfunction has been implicated in a number of diseases, and RBPs have traditionally been considered to be undruggable targets. Here, targeted degradation of RBPs is achieved based on the aptamer-based RNA-PROTAC, which consists of a genetically encoded RNA scaffold and a synthetic heterobifunctional molecule. The target RBPs can bind to their RNA consensus binding element (RCBE) on the RNA scaffold, while the small molecule can recruit E3 ubiquitin ligase to the RNA scaffold in a non-covalent manner, thereby inducing proximity-dependent ubiquitination and subsequent proteasome-mediated degradation of the target protein. Different RBPs targets, including LIN28A and RBFOX1, have been successfully degraded by simply replacing the RCBE module on the RNA scaffold. In addition, the simultaneous degradation of multiple target proteins has been realized by inserting more functional RNA oligonucleotides into the RNA scaffold.

摘要

RNA结合蛋白(RBPs)功能障碍与多种疾病有关,传统上RBPs被认为是不可成药的靶点。在此,基于适体的RNA-蛋白酶体靶向嵌合体实现了RBPs的靶向降解,其由基因编码的RNA支架和合成的异双功能分子组成。目标RBPs可与其在RNA支架上的RNA共有结合元件(RCBE)结合,而小分子能以非共价方式将E3泛素连接酶招募至RNA支架,从而诱导邻近依赖性泛素化以及随后蛋白酶体介导的目标蛋白降解。通过简单替换RNA支架上的RCBE模块,包括LIN28A和RBFOX1在内的不同RBPs靶点已成功被降解。此外,通过在RNA支架中插入更多功能性RNA寡核苷酸,实现了多种目标蛋白的同时降解。

相似文献

1
The aptamer-based RNA-PROTAC.基于适配体的RNA-蛋白降解靶向嵌合体。
Bioorg Med Chem. 2023 May 15;86:117299. doi: 10.1016/j.bmc.2023.117299. Epub 2023 Apr 27.
2
[Advances in the preclinical and clinical research of proteolysis targeting chimera].[蛋白酶靶向嵌合体的临床前和临床研究进展]
Sheng Wu Gong Cheng Xue Bao. 2023 Sep 25;39(9):3615-3627. doi: 10.13345/j.cjb.221040.
3
Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets.桥连蛋白水解靶向嵌合体(PROTAC)能够降解不可成药的靶标。
J Am Chem Soc. 2022 Dec 14;144(49):22622-22632. doi: 10.1021/jacs.2c09255. Epub 2022 Nov 30.
4
Recent Advances in PROTACs for Drug Targeted Protein Research.蛋白水解靶向嵌合体(PROTACs)在药物靶向蛋白研究中的最新进展。
Int J Mol Sci. 2022 Sep 7;23(18):10328. doi: 10.3390/ijms231810328.
5
Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic intervention.近年来,基于 cereblon 的蛋白酶靶向嵌合体的发现取得了进展,为治疗干预提供了潜在的可能性。
Future Med Chem. 2022 Oct;14(19):1403-1416. doi: 10.4155/fmc-2022-0149. Epub 2022 Sep 1.
6
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.从具有混杂弹头的选择性降解中吸取 PROTAC 设计的经验教训。
Cell Chem Biol. 2018 Jan 18;25(1):78-87.e5. doi: 10.1016/j.chembiol.2017.09.010. Epub 2017 Nov 9.
7
Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System.小分子邻近诱导化合物开发在利用泛素蛋白酶体系统的靶向蛋白降解中的当前挑战。
Molecules. 2022 Nov 22;27(23):8119. doi: 10.3390/molecules27238119.
8
Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency.共价蛋白水解靶向嵌合体的数学模型:催化效率的热力学和动力学基础。
J Med Chem. 2023 May 11;66(9):6239-6250. doi: 10.1021/acs.jmedchem.2c02076. Epub 2023 Apr 26.
9
The PROTAC technology in drug development.蛋白水解靶向嵌合体技术在药物研发中的应用。
Cell Biochem Funct. 2019 Jan;37(1):21-30. doi: 10.1002/cbf.3369. Epub 2019 Jan 2.
10
PROTACS: A technology with a gold rush-like atmosphere.PROTACs:一种有着淘金热般氛围的技术。
Eur J Med Chem. 2023 Feb 5;247:115037. doi: 10.1016/j.ejmech.2022.115037. Epub 2022 Dec 21.

引用本文的文献

1
RNA binding proteins (RBPs) on genetic stability and diseases.RNA结合蛋白(RBPs)与遗传稳定性及疾病
Glob Med Genet. 2024 Nov 30;12(1):100032. doi: 10.1016/j.gmg.2024.100032. eCollection 2025 Mar.
2
PROTACs coupled with oligonucleotides to tackle the undruggable.与寡核苷酸偶联的PROTAC用于攻克不可成药靶点。
Bioanalysis. 2025 Feb;17(4):261-276. doi: 10.1080/17576180.2025.2459528. Epub 2025 Feb 3.
3
PROTAC and Molecular Glue Degraders of the Oncogenic RNA Binding Protein Lin28.致癌性RNA结合蛋白Lin28的PROTAC和分子胶降解剂
Macromol Biosci. 2025 Mar;25(3):e2400427. doi: 10.1002/mabi.202400427. Epub 2024 Nov 22.
4
Targeted protein degradation: advances in drug discovery and clinical practice.靶向蛋白降解:药物发现和临床实践的进展。
Signal Transduct Target Ther. 2024 Nov 6;9(1):308. doi: 10.1038/s41392-024-02004-x.
5
RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy.RNA 剪接因子 RBFOX2 是癌症和心肌病进展的关键因素。
Clin Transl Med. 2024 Sep;14(9):e1788. doi: 10.1002/ctm2.1788.